Promacta 12.5 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FKPNY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,252
Award facts
- Contract value 100% obligated
- $13,251.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,251.75 to AmerisourceBergen Drug Corp for the supply of PROMACTA 12.5 mg tablets in packages of 30 units. This competitively awarded, firm fixed-price contract carries no set-aside designation and is scheduled for completion by October 6, 2025. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. PROMACTA is a prescription medication used to treat thrombocytopenia, a condition characterized by abnormally low platelet counts, making this a critical pharmaceutical supply for military and veteran healthcare systems supported by DLA.
This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As one of the nation's largest pharmaceutical distributors, AmerisourceBergen serves as a prime vendor for federal medical procurement across multiple therapeutic domains, supplying specialty medications, brand-name and generic drugs, vaccines, and medical devices to support military healthcare operations globally. The company's extensive federal contract portfolio demonstrates its established capability to meet DLA procurement requirements through competitive bidding and reliable delivery of critical pharmaceutical commodities to Defense Health Agency customers and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FKPNY?
SPE2DB25FKPNY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 15, 2025.
How much is contract SPE2DB25FKPNY worth?
The government has obligated $13,252 on SPE2DB25FKPNY.
Is contract SPE2DB25FKPNY an order under another contract?
Yes. SPE2DB25FKPNY is a delivery order under SPE2DB24D2101, an indefinite delivery contract.
Was contract SPE2DB25FKPNY competed?
The extent of competition for SPE2DB25FKPNY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award